ESTRO Brachytherapy for Prostate Cancer 2018

Customized dose prescription for permanent prostate

brachytherapy: insights from a multicenter analysis of

dosimetry outcomes.

Stone NN , Potters L , Davis BJ

Ciezki JP , Zelefsky MJ , Roach M , Fearn PA , Kattan MW , Stock RG

6 centers – 3928 PB patients with post-implant dosimetry results

Stratification in low- (2188), intermediate (n=1188) and high

(n=522) risk groups

AND

Into 3 BED groups:

–

< 140 Gy (n = 524)

–

140-200 Gy (n = 2284)

–

>200 Gy (n = 1115)

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1472-7